To evaluate use of a standardized, 3-tiered, seizure burden-based protocol for treatment of all electroencephalography (EEG)-confirmed seizures in a level IV neonatal intensive care unit (NICU).
Study Design
All infants admitted to the NICU with EEG-confirmed seizures over a 25-month period were enrolled in the study. We compared short-term outcomes before and after implementation of a standardized, 3-tiered protocol.
Results
A total of 107 infants were enrolled in the study. Use of midazolam infusions was reduced by 53.7% (p= 0.02). Midazolam infusion duration increased from 4 to 7.5 days (p = 0.003); however, when excluding 3 outliers, there was no significant difference between groups (p= 0.67). Duration of EEG monitoring decreased from 5 to 3 days (p= 0.005). Hospital length of stay was unchanged.
Conclusion
Implementation of a standardized, 3-tiered protocol for treatment of neonatal seizures improved short-term outcomes. Although not measured directly, reductions in EEG duration and midazolam use are promising indicators of overall seizure burden. More research is needed to evaluate impact on long-term neurodevelopmental outcomes.
AnnegersJFHauserWALeeJRRoccaWA. Incidence of acute symptomatic seizures in Rochester, Minnesota, 1935-1984. Epilepsia. 1995;36(4):327‐333.
2.
ShethRDHobbsGRMullettM. Neonatal seizures: incidence, onset, and etiology by gestational age. J Perinatol. 1999;19(1):40‐43.
3.
PadiyarSNusairatLKadriAAbu-ShaweeshJAlyH. Neonatal seizures in the U.S. national inpatient population: prevalence and outcomes. Pediatr Neonatol. 2020;61(3):300‐305.
4.
LegidoAClancyRRBermanPH. Neurologic outcome after electroencephalographically proven neonatal seizures. Pediatrics. 1991;88(3):583‐596.
5.
McBrideMCLaroiaNGuilletR. Electrographic seizures in neonates correlate with poor neurodevelopmental outcome. Neurology. 2000;55(4):506‐513.
6.
TekgulHGauvreauKSoulJ, et al.The current etiologic profile and neurodevelopmental outcome of seizures in term newborn infants. Pediatrics. 2006;117(4):1270‐1280.
7.
PisaniFCerminaraCFuscoCSistiL. Neonatal status epilepticus vs recurrent neonatal seizures: clinical findings and outcome. Neurology. 2007;69(23):2177‐2185.
8.
GlassHCGliddenDJeremyRJBarkovichAJFerrieroDMMillerSP. Clinical neonatal seizures are independently associated with outcome in infants at risk for hypoxic-ischemic brain injury. J Pediatr. 2009;155(3):318‐323.
9.
KharoshankayaLStevensonNJLivingstoneV, et al.Seizure burden and neurodevelopmental outcome in neonates with hypoxic-ischemic encephalopathy. Dev Med Child Neurol. 2016;58(12):1242‐1248.
10.
GlassHCNumisALGanoDBaliVRogersEE. Outcomes after acute symptomatic seizures in children admitted to a neonatal neurocritical care service. Pediatr Neurol. 2018;84:39‐45.
11.
SpagnoliCFalsaperlaRDeolmiMCorselloGPisaniF. Symptomatic seizures in preterm newborns: A review on clinical features and prognosis. Ital J Pediatr. 2018;44(1):115.
12.
CourchiaBBerkovitsMDKurtomWMoralTDBauerCR. Association between neonatal seizures and social-emotional development and adaptive behavior in extremely low birth weight infants. J Child Neurol. 2020;35(5):331‐335.
13.
SrinivasanCSachdevaRMorrowWR, et al.Standardized management improves outcomes after the Norwood procedure. Congenit Heart Dis. 2009;4(5):329‐337.
14.
RubboliGBeniczkySClausS, et al.A European survey on current practices in epilepsy monitoring units and implications for patients’ safety. Epilepsy Behav. 2015;44:179‐184.
15.
KogeJMatsumotoSNakaharaI, et al.Improving treatment times for patients with in-hospital stroke using a standardized protocol. J Neurol Sci. 2017;381:68‐73.
16.
MelendezEDwyerDDonellyD, et al.Standardized protocol is associated with a decrease in continuous albuterol use and length of stay in critical status asthmaticus. Pediatr Crit Care Med. 2020;21(5):451‐460.
17.
KeeneJCMorganLAAbendNS, et al.Treatment of neonatal seizures: comparison of treatment pathways from 11 neonatal intensive care units. Pediatr Neurol. 2022;128:67-74.
18.
HarrisMLMalloyKMLawsonSNRoseRSBussWFMietzschU. Standardized treatment of neonatal status epilepticus improves outcome. J Child Neurol. 2016;31(14):1546‐1554.
19.
Des JarlaisDCLylesCCrepazN. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004;94(3):361‐366.
20.
TsuchidaTNWusthoffCJShellhaasRA, et al.American Clinical Neurophysiology Society standardized EEG terminology and categorization for the description of continuous EEG monitoring in neonates: report of the American Clinical Neurophysiology Society critical care monitoring committee. J Clin Neurophysiol. 2013;30(2):161‐173.
21.
MurrayDMBoylanGBAliIRyanCAMurphyBPConnollyS. Defining the gap between electrographic seizure burden, clinical expression and staff recognition of neonatal seizures. Arch Dis Child Fetal Neonatal Ed. 2008;93(3):F187‐F191.
22.
ShellhaasRAChangTTsuchidaT, et al.The American Clinical Neurophysiology Society's guideline on continuous electroencephalography monitoring in neonates. J Clin Neurophysiol. 2011;28(6):611‐617.
23.
Hellström-WestasLBoylanGÅgrenJ. Systematic review of neonatal seizure management strategies provides guidance on anti-epileptic treatment. Acta Paediatr. 2015;104(2):123‐129.
24.
DonovanMDGriffinBTKharoshankayaLCryanJFBoylanGB. Pharmacotherapy for neonatal seizures: current knowledge and future perspectives. Drugs. 2016;76(6):647‐661.
25.
DizonMLVRaoRHamrickSE, et al.Practice variation in anti-epileptic drug use for neonatal hypoxic-ischemic encephalopathy among regional NICUs. BMC Pediatr. 2019;19(1):67.
26.
GlassHCKanJBonifacioSLFerrieroDM. Neonatal seizures: treatment practices among term and preterm infants. Pediatr Neurol. 2012;46(2):111‐115.
27.
GlassHCShellhaasRATsuchidaTN, et al.Seizures in preterm neonates: a multicenter observational cohort study. Pediatr Neurol. 2017;72:19‐24.
28.
PainterMJScherMSSteinAD, et al.Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341(7):485‐489.
29.
GlassHCShellhaasRAWusthoffCJ, et al.Contemporary profile of seizures in neonates: A prospective cohort study. J Pediatr. 2016;174:98‐103.e101.
30.
RaoLMHussainSAZakiT, et al.A comparison of levetiracetam and phenobarbital for the treatment of neonatal seizures associated with hypoxic-ischemic encephalopathy. Epilepsy Behav. 2018;88:212‐217.
31.
FavraisGUrsinoMMouchelC, et al.Levetiracetam optimal dose-finding as first-line treatment for neonatal seizures occurring in the context of hypoxic-ischaemic encephalopathy (LEVNEONAT-1): study protocol of a phase II trial. BMJ Open. 2019;9(1):e022739.
32.
KreimerAMLittrellRAGibsonJBLeungNR. Effectiveness of levetiracetam as a first-line anticonvulsant for neonatal seizures. J Pediatr Pharmacol Ther. 2019;24(4):320‐326.
33.
SharpeCReinerGEDavisSL, et al.Levetiracetam versus phenobarbital for neonatal seizures: a randomized controlled trial. Pediatrics. 2020;145(6):e20193182.
34.
MaitreNLSmolinskyCSlaughterJCStarkAR. Adverse neurodevelopmental outcomes after exposure to phenobarbital and levetiracetam for the treatment of neonatal seizures. J Perinatol. 2013;33(11):841‐846.
35.
AhmadKADesaiSJBennettMM, et al.Changing antiepileptic drug use for seizures in US neonatal intensive care units from 2005 to 2014. J Perinatol. 2017;37(3):296‐300.
36.
DaoKGiannoniEDieziMRoulet-PerezELebonS. Midazolam as a first-line treatment for neonatal seizures: Retrospective study. Pediatr Int. 2018;60(5):498‐500.
37.
HuKCChiuNCHoCSLeeSTShenEY. Continuous midazolam infusion in the treatment of uncontrollable neonatal seizures. Acta Paediatr Taiwan. 2003;44(5):279‐281.
38.
Castro CondeJRHernández BorgesAADoménech MartínezEGonzález CampoCPerera SolerR. Midazolam in neonatal seizures with no response to phenobarbital. Neurology. 2005;64(5):876‐879.
39.
NgETaddioAOhlssonA. Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit. Cochrane Database Syst Rev. 2012(6):Cd002052.
40.
PapettiLParisiPLeuzziV, et al.Metabolic epilepsy: an update. Brain Dev. 2013;35(9):827‐841.
41.
PearlPL. Amenable treatable severe pediatric epilepsies. Semin Pediatr Neurol. 2016;23(2):158‐166.
42.
EbingerMSchultzeCKönigS. Demographics and diagnosis of pyridoxine-dependent seizures. J Pediatr. 1999;134(6):795‐796.
43.
BaxterP. Pyridoxine-dependent and pyridoxine-responsive seizures. Dev Med Child Neurol. 2001;43(6):416‐420.
44.
SarnatHBSarnatMS. Neonatal encephalopathy following fetal distress: a clinical and electroencephalographic study. Arch Neurol. 1976;33(10):696‐705.
45.
PapileLABursteinJBursteinRKofflerH. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92(4):529‐534.
46.
SlaughterLAPatelADSlaughterJL. Pharmacological treatment of neonatal seizures: a systematic review. J Child Neurol. 2013;28(3):351‐364.
47.
SoulJS. Acute symptomatic seizures in term neonates: etiologies and treatments. Semin Fetal Neonatal Med. 2018;23(3):183‐190.
48.
CoJPEliaMEngel JrJ, et al.Proposal of an algorithm for diagnosis and treatment of neonatal seizures in developing countries. Epilepsia. 2007;48(6):1158‐1164.
49.
GlassHCSoulJSChuCJ, et al.Response to antiseizure medications in neonates with acute symptomatic seizures. Epilepsia. 2019;60(3):e20‐e24.
50.
KirtonAArmstrong-WellsJChangT, et al.Symptomatic neonatal arterial ischemic stroke: the International Pediatric Stroke Study. Pediatrics. 2011;128(6):e1402‐e1410.
51.
MietzschUCooperKLHarrisML. Successful reduction in electrode-related pressure ulcers during EEG monitoring in critically ill neonates. Adv Neonatal Care. 2019;19(4):262‐274.
52.
FitzgeraldMPKesslerSKAbendNS. Early discontinuation of antiseizure medications in neonates with hypoxic-ischemic encephalopathy. Epilepsia. 2017;58(6):1047‐1053.
53.
GlassHCSoulJSChangT, et al.Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol. 2021;78(7):817‐825.
54.
AnSKangCLeeHW. Artificial intelligence and computational approaches for epilepsy. J Epilepsy Res. 2020;10(1):8‐17.
55.
LiXCuiLZhangGQLhatooSD. Can big data guide prognosis and clinical decisions in epilepsy?Epilepsia. 2021;62(Suppl 2):S106‐s115.
